Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 09, 2020 08:00 ET | Source: Biond Biologics

Biond Biologics Announces Poster Presentations at AACR 2020 Virtual Annual Meeting

Published work highlights the preclinical development of BND-22, an anti-ILT2 multi-cell checkpoint inhibitor that enhances the anti-tumor activity of innate and adaptive immune cells Also, first...
June 01, 2020 08:00 ET | Source: Biond Biologics

Biond Biologics Appoints Jerome Zeldis, M.D., Ph.D., Former Chief Medical Officer of Celgene, to Board of Directors and Provides Corporate Update

Dr. Zeldis adds extensive clinical development expertise to Board BND-22, a novel immuno-oncology agent that targets the ILT2 receptor, on track for Q4 2020 IND submission MISGAV, Israel, June 01,...
November 25, 2019 07:00 ET | Source: Biond Biologics

Biond Biologics Appoints Immunotherapy Pioneer Alan Korman Ph.D. to Scientific Advisory Board

MISGAV, Israel, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Biond Biologics Ltd. (“Biond” or the “Company”), a privately-held Israeli biotech company, developing novel immunotherapies for cancer and a...